ad

Shilpa Medicare Ltd. (SHILPAMED): Shilpa Medicare Share Price Hits Fresh 52-Week High at Rs 822.50

11 Aug 202610:34 am

Shilpa Medicare Ltd. (SHILPAMED): Shilpa Medicare Share Price Hits Fresh 52-Week High at Rs 822.50

Shilpa Medicare Share Price stood at Rs 815.75, up 1.01% today, after touching a fresh 52-week high of Rs 822.50. The company’s market capitalisation is Rs 14,856.39 crore.

Shilpa Medicare Share Price was at Rs 815.75 on 11 August 2026 at 10:16 AM IST, up Rs 8.15 or 1.01% from the previous close of Rs 807.60, after the stock touched a fresh 52-week high of Rs 822.50. With a market capitalisation of Rs 14,856.39 crore and turnover of Rs 7.03 crore so far, the move has placed Shilpa Medicare Ltd. among closely watched names in Stock Market Today activity.

The verified data confirms a fresh one-year high, a higher intraday top at Rs 822.50, and active trading volume of 86,177 shares. That combination is enough to explain why the stock is trending in current Shilpa Medicare Stock News coverage, even though the supplied data does not establish a company-specific catalyst behind the move. For investors tracking Shilpa Medicare Share Price Today, the key facts are the breakout to a yearly high, the stock’s premium valuation multiples, and profitability ratios that stand above several sector benchmarks.

In this Univest stock analysis, the focus is on what happened today, how the current price compares with the previous close and intraday range, how Shilpa Medicare Fundamental Analysis looks on supplied metrics, and how the company compares with Healthcare peers and same-sector valuation benchmarks. For readers following Shilpa Medicare Share Price and broader Market News, the next step is to separate price action from valuation context.

Shilpa Medicare Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 815.75
Previous Close Rs 807.6
Today's Change +Rs 8.15 (+1.01%)
Day Open Rs 804.1
Fresh 52-Week High Rs 822.5
Day Low Rs 804.1
Current Volume 86,177
Turnover Rs 7.03 crore
Market Capitalisation Rs 14,856.39 crore

Shilpa Medicare Ltd. (SHILPAMED) traded at Rs 815.75. versus the previous close of Rs 807.6, a rise of 1.01%. The stock opened at Rs 804.1, reached Rs 822.5, touched Rs 804.1. Reported volume was 86,177.

Shilpa Medicare Share Price Today shows a clear fresh 52-week high event, with the stock opening at Rs 804.10, moving through the session to a high of Rs 822.50, and trading at Rs 815.75 versus the previous close of Rs 807.60. The day’s range and gain indicate sustained buying interest during the session rather than a brief isolated spike.

The stock opened at Rs 804.10, which was also the day’s low, and then advanced to Rs 822.50 before easing slightly to Rs 815.75. That still left the stock higher by Rs 8.15 on the day, translating into a 1.01% rise. Because the intraday high matched the 52-week peak at Rs 822.50, today’s move formally marked a new yearly high for the counter.

Trading participation was notable in absolute value terms as well. Current volume stood at 86,177 shares, while turnover was Rs 7.03 crore. Those figures matter because Shilpa Medicare Share Price News is not being driven only by a closing print; it is accompanied by active intraday participation and a higher traded value. In practical terms, that is why the stock is appearing in discussions around 52 Week High Stocks, Market Movers and stock updates within the Indian Stock Market.

Price action alone does not explain why a stock is moving, but it does confirm why it is attracting attention. For Univest readers tracking Shilpa Medicare Share Price Live patterns, the important takeaway is that the stock has extended its range to a fresh 52-week peak while holding above the previous close, which naturally shifts the discussion toward valuation and business quality rather than only momentum.

Shilpa Medicare Ltd. (SHILPAMED) Fundamental Analysis

Metric Value
Market Capitalisation Rs 14,856.39 crore
P/E Ratio 40.09x
P/B Ratio 9.77x
ROE 28.21%
ROCE 26.35%

Shilpa Medicare Ltd. was valued at a P/E ratio of 40.09x, a P/B ratio of 9.77x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric Value
Sector Healthcare
Benchmark Scope same sector
Company P/E Ratio 40.09x
Benchmark Median P/E 20.84x
Benchmark Average P/E 76.55x
Benchmark P/E Range 0x to 3,396.3x
Company P/B Ratio 9.77x
Benchmark Median P/B 1.93x
Company ROE 28.21%
Benchmark Median ROE 10.77%
Company ROCE 26.35%
Benchmark Median ROCE 13.35%
Company Market Capitalisation Rs 14,856.39 crore
Benchmark Median Market Cap Rs 142.3 crore

Shilpa Medicare Ltd. (SHILPAMED) is classified under sector: Healthcare.

Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 40.09x, which is above the benchmark median of 20.84x, a difference of +92.37%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Shilpa Medicare Ltd. (SHILPAMED) has a ROE of 28.21%, which is above the benchmark median of 10.77%, a difference of +161.93%. Shilpa Medicare Ltd. (SHILPAMED) has a ROCE of 26.35%, which is above the benchmark median of 13.35%, a difference of +97.38%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Kwality Pharmaceuticals Ltd. KPL 2,707.2 40.09 9.77 28.21 26.35
Beta Drugs Ltd. BETA 2,631.45 66.92 10.59 18.65 22.17
Dr Agarwals Eye Hospital Ltd. DRAGARWQ 2,601.85 34.14 7.04 -2.6 16.92
Sai Parenteral's Ltd. SAIPARENT 2,513.58 181.97 3.36 13.9 12.97
NGL Fine-Chem Ltd. NGLFINE 2,118.6 44.48 6.5 27.9 33.91

Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 40.09x compared with the displayed peer median of 44.48x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 18.65% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 22.17%, providing a capital-efficiency comparison. Shilpa Medicare Ltd. (SHILPAMED) has a market capitalisation of Rs 14,856.39 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Shilpa Medicare Ltd.

The fresh 52-week high has made the stock relevant for both event-driven traders and longer-horizon market watchers. Based strictly on verified data, these are the main reasons Shilpa Medicare Share Price is being tracked today on Univest.

  • Fresh price event: the stock touched a new 52-week high of Rs 822.50 and was trading at Rs 815.75, up 1.01% from Rs 807.60.
  • Active session participation: volume reached 86,177 shares with turnover of Rs 7.03 crore.
  • Large market size: market capitalisation stands at Rs 14,856.39 crore, far above the supplied sector median of Rs 142.30 crore and average of Rs 472.15 crore.
  • Profitability context: ROE of 28.21% and ROCE of 26.35% are above the same-sector medians of 10.77% and 13.35%.
  • Valuation context: P/E of 40.09 is above the sector median of 20.84, while P/B of 9.77 is materially above the sector median of 1.93.
  • Peer positioning: the company is much larger than the supplied peer group, with mixed but generally strong relative profitability.

About Shilpa Medicare Ltd.

Shilpa Medicare Ltd. is a listed company tracked under the Healthcare sector in the supplied market classification. In this article, the stock is identified by the symbol SHILPAMED and is being analysed in the context of a fresh 52-week high event.

The supplied benchmarking data places the company within a sector universe of 197 Healthcare companies. Peer references in the same market set include businesses from Pharmaceuticals & Drugs and Hospital & Healthcare Services, which helps frame how Shilpa Medicare Share Price is being assessed against listed Healthcare names on valuation, profitability and scale. On the supplied numbers, the company stands out more for size and return ratios than for low valuation.

For readers following Shilpa Medicare Company News and market context, the key point is that the stock is being evaluated here through verified price action, market capitalisation, valuation multiples and sector-relative profitability rather than through unsupported narrative claims.

Track Shilpa Medicare Share Price on Univest

Use Shilpa Medicare Ltd. (SHILPAMED) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors who follow Shilpa Medicare Share Price can use Univest to track live price moves, 52-week levels, market capitalisation, valuation ratios, peer comparison and broader stock analysis in one place. For a stock making a fresh yearly high, that makes it easier to separate event-led moves from fundamental context.

Univest also helps users monitor Shilpa Medicare Share Price Today alongside metrics such as P/E, P/B, ROE, ROCE, sector benchmarks and peer positioning. For readers looking beyond a single session move, Univest provides a structured way to follow Shilpa Medicare Stock News, compare its scale with Healthcare peers and keep track of whether the stock continues to hold investor attention after reaching a new 52-week peak.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

What is the latest Shilpa Medicare Share Price today?

Ans. Shilpa Medicare Share Price was Rs 815.75 on 11 August 2026 at 10:16 AM IST. The stock was up Rs 8.15, or 1.01%, from the previous close of Rs 807.60 during the session.

Did Shilpa Medicare hit a fresh 52-week high today?

Ans. Yes, Shilpa Medicare Share Price touched a fresh 52-week high of Rs 822.50 in intraday trade. The stock later traded at Rs 815.75, confirming a new one-year high event in today’s session.

Why is Shilpa Medicare Share Price rising today?

Ans. The supplied data confirms that Shilpa Medicare Share Price rose 1.01% and hit a fresh 52-week high at Rs 822.50. It also shows active trading with 86,177 shares and turnover of Rs 7.03 crore.

What does today’s price action show for Shilpa Medicare?

Ans. The stock opened at Rs 804.10, which was also the day’s low, and climbed to Rs 822.50 before trading at Rs 815.75. That intraday pattern shows strength above the previous close of Rs 807.60.

What is the market capitalisation of Shilpa Medicare Ltd.?

Ans. Shilpa Medicare Ltd. has a market capitalisation of Rs 14,856.39 crore. That is far above the same-sector median of Rs 142.30 crore and average of Rs 472.15 crore in the supplied Healthcare benchmark.

Is Shilpa Medicare expensive on valuation metrics?

Ans. On supplied figures, Shilpa Medicare trades at a P/E of 40.09 and P/B of 9.77. Its P/E is above the sector median of 20.84, while its P/B is well above the sector median of 1.93.

How strong are Shilpa Medicare’s profitability ratios?

Ans. The company’s ROE is 28.21% and ROCE is 26.35%. Both are above the same-sector median levels of 10.77% and 13.35%, indicating stronger profitability than the broader supplied Healthcare benchmark. ROE stands at 28.21%.

How does Shilpa Medicare compare with selected peers?

Ans. Shilpa Medicare’s market capitalisation of Rs 14,856.39 crore is much higher than supplied peers such as Beta Drugs, NGL Fine-Chem and Sai Parenteral's. Its profitability is also stronger than several peers, though valuation is not the lowest.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down